ProSci

EPM2A Antibody

Product Code:
 
PSI-7023
Product Group:
 
Primary Antibodies
Supplier:
 
ProSci
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence (IF)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
1 / 3
Western blot analysis of SW480 in SW480 cell lysate with EPM2A antibody at (A) 1 and (B) 2 μg/mL.
2 / 3
Immunocytochemistry of EPM2A in SW480 cells with EPM2A antibody at 2.5 μg/ml.
3 / 3
Immunofluorescence of EPM2A in SW480 cells with EPM2A antibody at 5 μg/ml.
❮❯

Western blot analysis of SW480 in SW480 cell lysate with EPM2A antibody at (A) 1 and (B) 2 μg/mL.
Immunocytochemistry of EPM2A in SW480 cells with EPM2A antibody at 2.5 μg/ml.
Immunofluorescence of EPM2A in SW480 cells with EPM2A antibody at 5 μg/ml.

No additional charges, what you see is what you pay! *

CodeSizePrice
PSI-7023-0.02mg0.02mg£150.00
Quantity:
PSI-7023-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Related Products
  • Show All

Further Information

Additional Names:
EPM2A Antibody: EPM2, MELF, Laforin, Lafora PTPase, LAFPTPase
Application Note:
EPM2A antibody can be used for detection of EPM2A by Western blot at 1 - 2 μg/mL.

Antibody validated: Western Blot in human samples; Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Background:
EPM2A Antibody: The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.
Background References:
  • Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 1998; 20:171-4.
  • Worby CA, Gentry MS, and Dixon JE. Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J. Biol. Chem. 2006; 281:30412-8.
Buffer:
EPM2A Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
EPM2A antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human EPM2A.

The immunogen is located within amino acids 190 - 240 of EPM2A.
NCBI Gene ID #:
7957
NCBI Official Name:
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
NCBI Official Symbol:
EPM2A
NCBI Organism:
homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
36 kDa
Protein Accession #:
NP_005661
Protein GI Number:
11321613
Purification:
EPM2A Antibody is affinity chromatography purified via peptide column.
Research Area:
Neuroscience
SPECIFICITY:
At least four isoforms of EPM2A are known to exist; this antibody will detect all but the shortest isoform.
Swissprot #:
O95278
User NOte:
Optimal dilutions for each application to be determined by the researcher.